Advanced search
Publication Cover
Aging Health Volume 7, 2011 - Issue 5
Journal homepage
89
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Cognitive Impairment in Elderly People with Type 2 Diabetes: Is There an Association and Why?

Jackie F Pricea Centre for Population Health Sciences, University of Edinburgh, Teviot Place, Edinburgh, EH4 7AL, UK. [email protected].: +44 131 650 3240Fax: +44 131 650 6909Correspondence[email protected]
View further author information
&
Mark WJ Strachanb Metabolic Unit, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UKView further author information
Pages 653-656 | Published online: 12 Oct 2011

Bibliography

  • Strachan MW , DearyIJ, EwingFM, FrierBM. Is Type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care20, 438–445(1997).
  • Awad N , GagnonM, MessierC. The relationship between impaired glucose tolerance, Type 2 diabetes, and cognitive function. J. Clin. Experimental Neuropsychol.26, 1044–1080(2004).
  • Cukierman T , GersteinHAC, WilliamsonJD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia48, 2460–2469(2005).
  • Biessels GJ , StaekenborgS, BrunnerE, BrayneC, ScheltensP. Risk of dementia in diabetes: a systematic review. Lancet Neurol.5, 64–74(2006).
  • Janson JT , LaedtkeT, ParisiJE, O‘BrienP, PetersenRC, ButlerPC. Increased risk of Type 2 diabetes in Alzheimer‘s disease. Diabetes53, 474–81(2004).
  • Okereke OI , KangJH, CookNRet al. Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults. J. American Geriatrics Society 56, 1028–1036(2008).
  • Manschot SM , BiesselsGJ, de Valk H et al. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with Type 2 diabetes. Diabetologia50, 2388–2397(2007).
  • Rafnsson SB , DearyIJ, FowkesFGR. Peripheral arterial disease and cognitive function. Vasc. Med.14, 51 (2009).
  • Starr JM , WardlawJ, FergusonK, MacLullichA, DearyIJ, MarshallI. Increased blood–brain barrier permeability in Type 2 diabetes demonstrated by gadolinium magnetic resonance imaging. J. Neurol. Neurosurgery Psychiatry74, 70–76(2003).
  • Ding J , StrachanMWJ, ReynoldsRet al. Diabetic retinopathy and cognitive decline in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 59(11), 2883–2889(2010).
  • Ryan CM , FreedMI, RoodJA, CobitzAR, WaterhouseBR, StrachanMW. Improving metabolic control leads to better working memory in adults with Type 2 diabetes. Diabetes Care29, 345–351(2006).
  • Whitmer RA , KarterAJ, YaffeK, QuesenberryCP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with Type 2 diabetes mellitus. JAMA301, 1565–1572(2009).
  • Aung PP , StrachanMWJ, FrierBM, ButcherI, DearyIJ, PriceJF. Severe hypoglycaemia is associated with cognitive decline in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetic Med.26, 24 (2009).
  • Qiu CX , WinbladB, FratiglioniL. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol.4, 487–499(2005).
  • Anstey KJ , LipnickiDM, LowLF. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am. J. Geriatric Psychiatry16, 343–354(2008).
  • McGuinness B , CraigD, BullockR, PassmoreP. Statins for the prevention of dementia. Cochr. Database System. Rev.2, CD003160 (2009).
  • Marioni R , StrachanMWJ, ReynoldsRet al. Association between raised inflammatory markers and cognitive decline in elderly people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 59(3), 710–713(2001).
  • Reynolds RM , StrachanMWJ, LabadJet al. Morning cortisol levels and cognitive abilities in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 33, 714–720(2010).
  • Marioni RE , LoweGDO, RumleyAet al. Blood rheology and cognition in the Edinburgh Type 2 Diabetes Study. Age Aging 39, 354–359(2010).
  • Marioni RE , DearyIJ, MurrayGDet al. Genetic variants associated with altered plasma levels of C-reactive protein are not associated with late-life cognitive ability in four Scottish samples. Behav. Genet. 40, 3–11(2010).
  • Didelez V , SheehanN. Mendelian randomisation as an instrumental variable approach to causal inference. Statistical Methods Med. Res.16, 309–330(2007).
  • Perry T , LahiriDK, SambamurtiKet al. Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron. J. Neurosci. Res. 72, 603–612(2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.